Clinical Trial Update: The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer [NA]

View source ↗

Summary

Clinical trial update on the efficacy of neoadjuvant atezolizumab in advanced urothelial carcinoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Urothelial Carcinoma | NA | Status: UNKNOWN